Business
Vortex co-founder receives US Presidential award
Vortex co-founder receives US Presidential award.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 6459Q NetScientific PLC 01 March 2016 \n\n \nNetScientific plc\n \nVortex BioSciences co-founder receives US Presidential award for groundbreaking \"Liquid Biopsy\" technique\nLondon, UK - 1 March 2016 - NetScientific plc (\"NetScientific\" or the \"Group\", AIM: NSCI), the transatlantic biomedical and healthcare technology group notes its operating subsidiary, Vortex Biosciences' ('Vortex') announcement about its co-founder receiving the US Presidential Early Career Award for Scientists and Engineers (PECASE). The award is the highest honor bestowed by the United States government for accomplishments in science and engineering. \nProfessor Dino Di Carlo, co-founder and Chief Scientific Advisor of Vortex, received the award for devising a first-of-its-kind technique to quickly separate rare and information-rich circulating tumor cells from common blood cells. This innovation has profound implications for early diagnosis of cancer and precision medicine development. Di Carlo's discovery is the underlying technology behind Vortex BioSciences. The company was formed in 2012 to commercialize the new technique for numerous applications, such as diagnosis, treatment selection and monitoring, new compound discovery and development and next generation sequencing. \nCommenting on the news, NetScientific's Chief Executive Officer, Francois R. Martelet said: \"Vortex is our lead diagnostics company and we are delighted for Dino Di Carlo to have received this outstanding recognition for his work. This further endorses Vortex's core technology as we continue to accelerate its development towards a potential best-in-class technology.\"\nThe full text of the announcement from Vortex can be found below:\nContact Details\n \nNetScientific \nFrançois R. Martelet, M.D., CEO Tel: +44 (0)20 3514 1800\nMark Nanovich, Interim CFO &n...